Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Sexual Transmission of Infection”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT00002079
What this trial is testing

Phase II Study of the Safety and Surrogate Marker Efficacy of Butyldeoxynojirimycin (SC-48334) and AZT in Symptomatic HIV-1 Infected Patients With 200 - 500 CD4+ Cells/mm3. (NOTE: Asymptomatic HIV-1 Infected Patients Also Eligible)

Who this might be right for
HIV Infections
G D Searle
Post-approval studies (Phase 4)Study completedNCT00976040
What this trial is testing

Optimal Time to Start Antiretroviral Therapy in HIV-infected Adults With Cryptococcal Meningitis

Who this might be right for
Cryptococcal MeningitisHIV Infections
Botswana-UPenn Partnership 28
Testing effectiveness (Phase 2)Study completedNCT00071890
What this trial is testing

Phase II/III Study Evaluating the Effect of IL-2 on Preservation of the CD4 T-Lymphocytes After Interruption of Antiretroviral Treatment in HIV-Infected Patients With CD4 T-Lymphocyte Count Greater Than 500 Cells/mm3 Who Received Antiretroviral Tx

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 148
Large-scale testing (Phase 3)Not Yet RecruitingNCT05173324
What this trial is testing

Integration of HPV Vaccination and HPV-based Cervical Screening Into ARV Clinics: the H2VICTORY Trial

Who this might be right for
HPV Infection
International Agency for Research on Cancer 8,000
Early research (Phase 1)Study completedNCT00000680
What this trial is testing

A Phase I Study of Autologous, Activated CD8(+) Lymphocytes Expanded In Vitro and Infused With or Without Recombinant Interleukin-2 to Patients With AIDS or Severe ARC

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 6
Large-scale testing (Phase 3)Study completedNCT00450580
What this trial is testing

HIV-1 Infection Study of Once a Day Versus Twice a Day Protease Inhibitor in Antiretroviral Treatment Naive Adults

Who this might be right for
Infection, Human Immunodeficiency Virus IHIV-1 Infection
ViiV Healthcare 212
Large-scale testing (Phase 3)Ended earlyNCT00122525
What this trial is testing

Effect of Male Circumcision on HIV Incidence (ANRS 1265)

Who this might be right for
HIV InfectionsHerpes GenitalisVenereal Diseases
French National Agency for Research on AIDS and Viral Hepatitis 3,274
Testing effectiveness (Phase 2)WithdrawnNCT00614640
What this trial is testing

Safety and Tolerability of a Therapeutic DNA Dendritic Cell Vaccine in HIV-Infected Children, Adolescents, and Young Adults

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID)
Large-scale testing (Phase 3)Study completedNCT02422797
What this trial is testing

Regimen Switch to Dolutegravir + Rilpivirine From Current Antiretroviral Regimen in Human Immunodeficiency Virus Type 1 Infected and Virologically Suppressed Adults (SWORD-2)

Who this might be right for
HIV Infections
ViiV Healthcare 518
Not applicableUnknownNCT04482010
What this trial is testing

ANRS 12392 Sanu Gundo

Who this might be right for
HIV Infections
ANRS, Emerging Infectious Diseases 265
Testing effectiveness (Phase 2)Ended earlyNCT00095576
What this trial is testing

Investigation of V520 in an HIV Vaccine Proof-of-Concept Study (V520-023)

Who this might be right for
AIDSHIV Infections
Merck Sharp & Dohme LLC 3,000
Testing effectiveness (Phase 2)Study completedNCT01803074
What this trial is testing

Study to Evaluate a HIV Drug for the Treatment of HIV Infection

Who this might be right for
Infection, Human Immunodeficiency VirusHIV Infections
ViiV Healthcare 107
Testing effectiveness (Phase 2)Study completedNCT00213018
What this trial is testing

Safety, Acceptability and Preliminary Effectiveness of Carraguard™ (PC-515) in Preventing HIV/STI Transmission

Who this might be right for
HIV InfectionsChlamydia TrachomatisNeisseria Gonorrhoeae+2 more
Population Council 400
Not applicableStudy completedNCT00002076
What this trial is testing

Pilot Study of Oral Fluconazole in the Treatment of Acute Cryptococcal Meningitis

Who this might be right for
Meningitis, CryptococcalHIV Infections
Pfizer
Testing effectiveness (Phase 2)Study completedNCT00081588
What this trial is testing

An Open Label Trial of TMC114/RTV in HIV-1 Infected, Treatment-experienced Subjects.

Who this might be right for
HIV Infection
Tibotec Pharmaceuticals, Ireland 555
Early research (Phase 1)Study completedNCT00000810
What this trial is testing

Randomized, Phase I/II, Dose-Ranging, Open-Label Trial of the Anti-HIV Activity of Delavirdine Mesylate (DLV; U-90,152S)

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 120
Early research (Phase 1)Study completedNCT07629310
What this trial is testing

To Evaluate the Safety of JL18008

Who this might be right for
HIV Infections
Jecho Biopharmaceuticals Co., Ltd. 40
Testing effectiveness (Phase 2)Study completedNCT00000820
What this trial is testing

A Phase II Study of Low-Dose Interleukin-2 by Subcutaneous Injection in Combination With Antiretroviral Therapy Versus Antiretroviral Therapy Alone in Patients With HIV-1 Infection and at Least 3 Months Stable Antiretroviral Therapy

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 104
Not applicableStudy completedNCT01335360
What this trial is testing

Pharmacokinetic Evaluation of Changes in Nevirapine AUC Due to Differences in Weight

Who this might be right for
HIV Infection
Western University of Health Sciences 21
Not applicableStudy completedNCT00016588
What this trial is testing

Tenofovir Disoproxil Fumarate (TDF) in HIV-1 Patients Who Have Never Taken Anti-HIV Drugs

Who this might be right for
HIV Infections
Gilead Sciences
Next Page